After six weeks in the hospital, 23‑year‑old Daniel Cressy leaves with hope for a functional cure and a future where he can finally pursue his dream of flying.

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in this space, including a high-profile acquisition and key ...

InVita Healthcare Technologies, a leader in blood and other biologics software, and Gulf Coast Blood, one of the nation's largest community blood centers, today announced new advanced therapy capabilities developed in collaboration and introduced in InVita's HemaConnect 2.

I am deeply humbled by the decades of support from people around the world. It is an honor to share this painful yet

Researchers from the Keck School of Medicine of USC have made an important advance toward understanding—and potentially treating—a rare cardiomyopathy (heart muscle disease) that is present from birth.

Precedence Research introduces its Advanced Cell and Gene Therapy Intelligence Platform, turning complex data into actionable insights to empower strategic decisions in the evolving CGT landscape. Designed to support stakeholders across the CGT sector,

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more.

Cell and gene therapies (CGT) continue to advance in the pharmaceutical industry. Despite continued investment in R&D, the space still faces significant barriers. Primarily, the expensive nature of the treatments and complexity of manufacturing them.

"A powerful tool for disease detection and post-treatment monitoring."

A new study finds that bacteria can actively block the transfer of beneficial genes to neighboring cells, using specialized proteins to specifically destroy shared DNA before it spreads. This challenges the long-held view that bacteria freely exchange genetic material and reveals a more competitive system in which microbes tightly control who gets access to valuable traits,